Why DaVita HealthCare (DVA) is a Top Growth Stock for the Long-Term

DaVita HealthCare (DVA), a prominent U.S. dialysis service provider, is highlighted as a top growth stock despite its #3 (Hold) Zacks Rank. The company boasts an 'A' rating for both its Growth and overall VGM (Value, Growth, Momentum) Style Scores, underpinned by a projected 12.9% year-over-year earnings growth for the current fiscal year. Furthermore, fiscal 2025 earnings estimates have seen recent upward revisions, increasing by $0.17 to $10.93 per share, complementing DVA's average earnings surprise of 4.7%, positioning it as a compelling option for growth investors.

Analysis

DaVita Inc. (DVA) presents a notable case for growth-focused investors, as highlighted by its 'A' ratings for both its Growth Style Score and its composite VGM Score within the Zacks framework. This positive assessment is substantiated by a specific forecast for 12.9% year-over-year earnings growth in the current fiscal year. Furthermore, forward-looking sentiment appears constructive, with the Zacks Consensus Estimate for fiscal 2025 earnings increasing by $0.17 to $10.93 per share following upward revisions by two analysts in the last 60 days. The company's operational track record lends credibility to these projections, as evidenced by an average positive earnings surprise of 4.7%. However, these strong growth indicators are tempered by the stock's neutral Zacks Rank of #3 (Hold), suggesting a lack of immediate, powerful catalysts that would warrant a higher rating, despite the strong underlying fundamental metrics.

Key Decisions for Investors

• Investors with a growth-oriented strategy should consider DVA for their portfolios, given its strong 'A' rated growth score and a projected 12.9% YoY earnings growth.
• The neutral #3 (Hold) rank serves as a point of caution, indicating that while fundamentals are strong, a significant near-term price catalyst may be absent, warranting a balanced assessment rather than an aggressive buy.
• Monitor future earnings estimate revisions for DVA, as the positive trend in analyst expectations is a key pillar of the bull case presented in the analysis and is crucial for sustaining a growth narrative.